Benzamide, N-[3-[(6-chloro-1,2,3,4-tetrahydro-9-acridinyl)amino]propyl]-4-[(1E)-3-(hydroxyamino)-3-oxo-1-propen-1-yl]-

Request For Quotation
Benzamide, N-[3-[(6-chloro-1,2,3,4-tetrahydro-9-acridinyl)amino]propyl]-4-[(1E)-3-(hydroxyamino)-3-oxo-1-propen-1-yl]- Suppliers list
Company Name: Shanghai Beckham Medical Technology Co., Ltd  
Tel: 13816613772
Email: huahero21@sina.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: TargetMol Chemicals Inc.  
Tel: 13564774135
Email: marketing@targetmol.com

Benzamide, N-[3-[(6-chloro-1,2,3,4-tetrahydro-9-acridinyl)amino]propyl]-4-[(1E)-3-(hydroxyamino)-3-oxo-1-propen-1-yl]- manufacturers

  • AChE/HDAC-IN-1
  • AChE/HDAC-IN-1 pictures
  • $1520.00
  • 2026-04-21
  • CAS:2414053-06-6
  • Purity:
  • Supply Ability: 10g
Benzamide, N-[3-[(6-chloro-1,2,3,4-tetrahydro-9-acridinyl)amino]propyl]-4-[(1E)-3-(hydroxyamino)-3-oxo-1-propen-1-yl]- Basic information
Product Name:Benzamide, N-[3-[(6-chloro-1,2,3,4-tetrahydro-9-acridinyl)amino]propyl]-4-[(1E)-3-(hydroxyamino)-3-oxo-1-propen-1-yl]-
Synonyms:Benzamide, N-[3-[(6-chloro-1,2,3,4-tetrahydro-9-acridinyl)amino]propyl]-4-[(1E)-3-(hydroxyamino)-3-oxo-1-propen-1-yl]-;AChE/HDAC-IN-1
CAS:2414053-06-6
MF:C26H27ClN4O3
MW:478.97
EINECS:
Product Categories:
Mol File:2414053-06-6.mol
Benzamide, N-[3-[(6-chloro-1,2,3,4-tetrahydro-9-acridinyl)amino]propyl]-4-[(1E)-3-(hydroxyamino)-3-oxo-1-propen-1-yl]- Structure
Benzamide, N-[3-[(6-chloro-1,2,3,4-tetrahydro-9-acridinyl)amino]propyl]-4-[(1E)-3-(hydroxyamino)-3-oxo-1-propen-1-yl]- Chemical Properties
density 1.340±0.06 g/cm3(Predicted)
pka8+-.0.23(Predicted)
Safety Information
MSDS Information
Benzamide, N-[3-[(6-chloro-1,2,3,4-tetrahydro-9-acridinyl)amino]propyl]-4-[(1E)-3-(hydroxyamino)-3-oxo-1-propen-1-yl]- Usage And Synthesis
UsesCOX-2-IN-23 (compound A10) is a potent both AChE and HDAC inhibitor with IC50 values of 0.12 and 0.23 nM. COX-2-IN-23 exhibits antioxidant activity and metal chelating properties. COX-2-IN-23 can be used in alzheimer's disease research[1].
IC 50HDAC: 0.23 nM (IC50)
References[1] Xu A, et al. Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation. Bioorg Chem. 2020 May;98:103721. DOI:10.1016/j.bioorg.2020.103721
Benzamide, N-[3-[(6-chloro-1,2,3,4-tetrahydro-9-acridinyl)amino]propyl]-4-[(1E)-3-(hydroxyamino)-3-oxo-1-propen-1-yl]- Preparation Products And Raw materials
Tag:Benzamide, N-[3-[(6-chloro-1,2,3,4-tetrahydro-9-acridinyl)amino]propyl]-4-[(1E)-3-(hydroxyamino)-3-oxo-1-propen-1-yl]-(2414053-06-6) Related Product Information
Carbamazepine [4-[(Hydroxyamino)carbonyl]phenyl]carbamic acid [6-[(diethylamino)methyl]-2-naphthalenyl]methyl ester Tucidinostat (Chidamide) 4-Phenylbutyric acid Entinostat (1S,4Z,7S,10S,11E,20R)-4-ethylidene-7,20-dipropan-2-yl-9-oxa-15,16-dit hia-3,6,18,21-tetrazabicyclo[8.7.6]tricos-11-ene-2,5,8,19,22-pentone